Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Bancroft, EK"'
Autor:
Saya, S, Killick, E, Thomas, S, Taylor, N, Bancroft, EK, Rothwell, J, Benafif, S, Dias, A, Mikropoulos, C, Pope, J, Chamberlain, A, Gunapala, R, SIGNIFY Study Steering Committee, Izatt, L, Side, L, Walker, L, Tomkins, S, Cook, J, Barwell, J, Wiles, V, Limb, L, Eccles, D, Leach, MO, Shanley, S, Gilbert, FJ, Hanson, H, Gallagher, D, Rajashanker, B, Whitehouse, RW, Koh, D-M, Sohaib, SA, Evans, DG, Eeles, RA
In the United Kingdom, current screening guidelines for TP53 germline mutation carriers solely recommends annual breast MRI, despite the wide spectrum of malignancies typically seen in this group. This study sought to investigate the role of one-off
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926fb040ea096de752cad948fb6de92f
https://openaccess.sgul.ac.uk/id/eprint/108985/1/s10689-017-9965-1.pdf
https://openaccess.sgul.ac.uk/id/eprint/108985/1/s10689-017-9965-1.pdf
Autor:
Bancroft, EK, Page, EC, Castro, E, Lilja, H, Vickers, A, Sjoberg, D, Assel, M, Foster, CS, Mitchell, G, Drew, K, Maehle, L, Axcrona, K, Evans, DG, Bulman, B, Eccles, D, McBride, D, van Asperen, C, Vasen, H, Kiemeney, LA, Ringelberg, J, Cybulski, C, Wokolorczyk, D, Selkirk, C, Hulick, PJ, Bojesen, A, Skytte, AB, Lam, J, Taylor, L, Oldenburg, R, Cremers, R, Verhaegh, G, van Zelst-Stams, WA, Oosterwijk, JC, Blanco, I, Salinas, M, Cook, J, Rosario, DJ, Buys, S, Conner, T, Ausems, MG, Ong, KR, Hoffman, J, Domchek, S, Powers, J, Teixeira, MR, Maia, S, Foulkes, WD, Taherian, N, Ruijs, M, Helderman-van den Enden, AT, Izatt, L, Davidson, R, Adank, MA, Walker, L, Schmutzler, R, Tucker, K, Kirk, J, Hodgson, S, Harris, M, Douglas, F, Lindeman, GJ, Zgajnar, J, Tischkowitz, M, Clowes, VE, Susman, R, Cajal, TRY, Patcher, N, Gadea, N, Spigelman, A, van Os, T, Liljegren, A, Side, L, Brewer, C, Brady, AF, Donaldson, A, Stefansdottir, V, Friedman, E, Chen-Shtoyerman, R, Amor, DJ, Copakova, L, Barwell, J, Giri, VN, Murthy, V, Nicolai, N, Teo, SH, Greenhalgh, L, Strom, S, Henderson, A, McGrath, J, Gallagher, D, Aaronson, N, Ardern-Jones, A, Bangma, C, Dearnaley, D, Costello, P, Eyfjord, J, Rothwell, J, Falconer, A, Gronberg, H, Hamdy, FC, Johannsson, O, Khoo, V, Kote-Jarai, Z, Lubinski, J, Axcrona, U, Melia, J, McKinley, J, Mitra, AV, Moynihan, C, Rennert, G, Suri, M, Wilson, P, Killick, E, Moss, S, Eeles, RA, Taylor, N, Pope, J, Saya, S, Martin, S, Keating, D, Petelin, L, Murphy, M, Doherty, R, Pratt, S, Murphy, D, Cleeve, L, Miller, C, Stapleton, A, Chong, M, Suthers, G, Andrews, L, Duffy, J, Millard, R, Ward, R, Williams, R, Stricker, P, Bowman, M, Patel, M, O'Connell, S, Hunt, C, Smyth, C, Frydenberg, M, Shackleton, K, McGaughran, J, Boon, M, Pachter, N, Townshend, S, Schofield, L, Gleeson, M, Scott, R, Burke, J, Patterson, B, Bacic, S, Swindle, P, Aprikian, A, Bojeson, A, Cruger, D, Osther, P, Gerdes, AM, Rhiem, K, Luedtke-Heckenkamp, K, Ochsendorf, N, Fiddike, K, Sarin, R, Awatagiri, K, Ghonge, S, Kowtal, P, Mulgund, G, Bambury, R, Farrell, M, Gallagher, F, Ben-Yehoshua, SJ, Nissani, R, Appelman, Z, Moriel, E, Radice, P, Valdagni, R, Magnani, T, Meng, TH, Yoon, SY, Thong, MK, Kiemeney, B, Van der Luijt, RB, Moller, P, Brennhovd, B, Medvik, H, Hanslien, E, Peixoto, A, Henrique, R, Oliveira, J, Goncalves, N, Araujo, L, Seixas, M, Joao, PS, Nogueira, P, Krajc, M, Vrecar, A, Capella, G, Fisas, D, Balmana, J, Morote, J, Hjalm-Eriksson, M, Ekdahl, KJ, Carlsson, S, Hanson, H, Shanley, S, Goh, C, Wiggins, J, Kohut, K, Van As, N, Thompson, A, Ogden, C, Borley, N, Woodhouse, C, Kumar, P, Mercer, C, Paterson, J, Taylor, A, Newcombe, B, Halliday, D, Stayner, B, Fleming-Brown, D, Brice, G, Homfray, T, Hammond, C, Potter, A, Renton, C, Searle, A, Hill, K, Goodman, S, Garcia, L, Devlin, G, Everest, S, Nadolski, M, Jobson, I, Paez, E, Tomkins, S, Pichert, G, Jacobs, C, Langman, C, Weston, M, Dorkins, H, Melville, A, Kosicka-Slawinska, M, Cummings, C, Kiesel, V, Bartlett, M, Randhawa, K, Ellery, N, Male, A, Simon, K, Rees, K, Compton, C, Tidey, L, Nevitt, L, Ingram, S, Catto, J, Howson, J, Chapman, C, Cole, T, Heaton, T, Burgess, L, Longmuir, M, Watt, C, Duncan, A, Kockelbergh, R, Sattar, A, Kaemba, B, Sidat, Z, Patel, N, Siguake, K, Birt, A, Poultney, U, Umez-Eronini, N, Mom, J, Roberts, G, Woodward, A, Sutton, V, Cornford, P, Treherne, K, Griffiths, J, Cogley, L, Rubinstein, W, Brendler, C, Helfand, B, McGuire, M, Kaul, K, Shevrin, D, Weissman, S, Newlin, A, Vogel, K, Weiss, S, Goldgar, D, Venne, V, Stephenson, R, Dechet, C, Arun, B, Davis, JW, Yamamura, Y, Gross, L
Publikováno v:
EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers. IMPACT (Identification of Men with a genetic predisposi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c5a815b40531304e841ccbdc7624fba7
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9155
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9155
Autor:
Mitra, AV, Bancroft, EK, Barbachano, Y, Page, EC, Foster, CS, Jameson, C, Mitchell, G, Lindeman, GJ, Stapleton, A, Suthers, G, Evans, DG, Cruger, D, Blanco, I, Mercer, C, Kirk, J, Maehle, L, Hodgson, S, Walker, L, Izatt, L, Douglas, F, Tucker, K, Dorkins, H, Clowes, V, Male, A, Donaldson, A, Brewer, C, Doherty, R, Bulman, B, Osther, PJ, Salinas, M, Eccles, D, Axcrona, K, Jobson, I, Newcombe, B, Cybulski, C, Rubinstein, WS, Buys, S, Townshend, S, Friedman, E, Domchek, S, Cajal, TRY, Spigelman, A, Teo, SH, Nicolai, N, Aaronson, N, Ardern-Jones, A, Bangma, C, Dearnaley, D, Eyfjord, J, Falconer, A, Gronberg, H, Hamdy, F, Johannsson, O, Khoo, V, Kote-Jarai, Z, Lilja, H, Lubinski, J, Melia, J, Moynihan, C, Peock, S, Rennert, G, Schroder, F, Sibley, P, Suri, M, Wilson, P, Bignon, YJ, Strom, S, Tischkowitz, M, Liljegren, A, Ilencikova, D, Abele, A, Kyriacou, K, van Asperen, C, Kiemeney, L, Easton, DF, Eeles, RA
Publikováno v:
BJU International, 107, 28-39
BJU International, 107(1), 28-39. Wiley-Blackwell Publishing Ltd
BJU International, 107(1), 28-39. Wiley-Blackwell
BJU International, 107, 1, pp. 28-39
BJU INTERNATIONAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BJU International, 107(1), 28-39. Wiley-Blackwell Publishing Ltd
BJU International, 107(1), 28-39. Wiley-Blackwell
BJU International, 107, 1, pp. 28-39
BJU INTERNATIONAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
What's known on the subject? and What does the study add? Scientists have found a number of genetic factors that increase prostate cancer risk, including heritable mutations in the genes BRCA1 and BRCA2. These mutations are not common but can have ma
Autor:
Cremers, R, Eeles, RA, Bancroft, EK, Ringelberg, J, Vasen, HF, van Asperen, CJ, Schalken, JA, Verhaegh, GW, Kiemeney, LA, Aaronson, N, Ardem-Jones, A, Bangma, C.H., Castro, E, Dearnaley, D, Eccles, D, Evans, DGR, Eyfjord, J, Falconer, A, Foster, CS (Christopher), Gronberg, H, Hamdy, FC, Johansson, O, Khoo, V, Kote-Jarai, Z, Lija, H, Lubinski, J, Maehle, L, Melia, J, Mikropoulos, C, Mitchell, G, Mitra, AV, Moss, S, Moynihan, C, Page, EC, Rennert, G, Suri, M, Wilson, P
Publikováno v:
Urologic Oncology-Seminars and Original Investigations, 33(5), 202e19-202e28. Elsevier Inc.
Urologic Oncology-Seminars and Original Investigations, 33, 202.e19-28
Urologic Oncology-Seminars and Original Investigations, 33, 5, pp. 202.e19-28
Urologic Oncology-Seminars and Original Investigations, 33, 202.e19-28
Urologic Oncology-Seminars and Original Investigations, 33, 5, pp. 202.e19-28
Contains fulltext : 154257.pdf (Publisher’s version ) (Open Access) OBJECTIVE: To evaluate the additive value of the prostate cancer gene 3 (PCA3) urine test to serum prostate-specific antigen (PSA) in prostate cancer (PC) screening among breast ca
Autor:
Kohut K; Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, UK.; South West Thames Centre for Genomics, Clinical Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK., Morton K; Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, UK., Turner L; Patient and Public Collaborator, University of Southampton, Southampton, UK., Foster R; Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, UK., Bancroft EK; Urology Genetics, The Royal Marsden NHS Foundation Trust, Sutton, UK.; Oncogenetics Team, The Institute of Cancer Research, Sutton, UK., Esplen MJ; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada., Hanson H; Peninsula Clinical Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.; Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK., Hurley K; Stanford R Weiss, MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, Ohio, USA., Snape K; South West Thames Centre for Genomics, Clinical Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK., Eccles D; Faculty of Medicine, University of Southampton, Southampton, UK., Foster C; Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, UK.
Publikováno v:
Psycho-oncology [Psychooncology] 2024 Sep; Vol. 33 (9), pp. e9312.
Autor:
Bancroft EK; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK., Page EC; Oncogenetics Team, Institute of Cancer Research, London, UK., Brook MN; Oncogenetics Team, Institute of Cancer Research, London, UK., Pope J; Oncogenetics Team, Institute of Cancer Research, London, UK., Thomas S; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK., Myhill K; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK., Helfand BT; Division of Urology, John and Carol Walter Center for Urological Health, NorthShore University HealthSystem, Evanston, IL, USA., Talaty P; Division of Urology, John and Carol Walter Center for Urological Health, NorthShore University HealthSystem, Evanston, IL, USA., Ong KR; West Midlands Regional Clinical Genetics Service, Birmingham Women's Hospital, Birmingham, UK., Douglas E; West Midlands Regional Clinical Genetics Service, Birmingham Women's Hospital, Birmingham, UK., Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK., Rosario DJ; Royal Hallamshire Hospital, Sheffield, UK., Salinas M; Hereditary Cancer Program, ICO (Catalan Institute of Oncology), Barcelona, Spain., Buys SS; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Anson J; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Davidson R; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK., Longmuir M; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK., Side L; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Eccles DM; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.; The University of Southampton Medical School, Southampton, UK., Tischkowitz M; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK.; Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Taylor A; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK., Cruellas M; Hereditary Cancer Genetics Group, Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Ballestero EP; Hereditary Cancer Genetics Group, Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Cleaver R; Peninsula Clinical Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Varughese M; Peninsula Clinical Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Barwell J; University of Leicester, Leicester, UK.; University Hospitals Leicester, Leicester, UK., LeButt M; University Hospitals Leicester, Leicester, UK., Greenhalgh L; Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool, UK., Hart R; Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool, UK., Azzabi A; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Jobson I; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Cogley L; Peninsular Genetics, Derriford Hospital, Plymouth, UK., Evans DG; Genomic Medicine, Manchester Academic Health Sciences Centre, Manchester University NHS Foundation Trust, Manchester, UK., Rothwell J; Genomic Medicine, Manchester Academic Health Sciences Centre, Manchester University NHS Foundation Trust, Manchester, UK., Taylor N; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK., Hogben M; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK., Saya S; Oncogenetics Team, Institute of Cancer Research, London, UK.; The University of Melbourne, Melbourne, Australia., Eeles RA; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK., Aaronson NK; Netherlands Cancer Institute, Amsterdam, Netherlands.
Publikováno v:
BJU international [BJU Int] 2024 Sep; Vol. 134 (3), pp. 484-500. Date of Electronic Publication: 2024 Jun 05.
Autor:
Bancroft EK; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
Publikováno v:
BJU international [BJU Int] 2024 Nov; Vol. 134 (5), pp. 853. Date of Electronic Publication: 2024 Jul 26.
Autor:
Dias A; Oncogenetics Team The Institute of Cancer Research London UK.; Instituto Nacional de Cancer Jose de Alencar Gomes da Silva INCA Rio de Janeiro Brazil., Brook MN; Oncogenetics Team The Institute of Cancer Research London UK., Bancroft EK; Oncogenetics Team The Institute of Cancer Research London UK.; Academic Urology Unit Royal Marsden NHS Foundation Trust London UK., Page EC; Oncogenetics Team The Institute of Cancer Research London UK., Chamberlain A; Academic Urology Unit Royal Marsden NHS Foundation Trust London UK., Saya S; Oncogenetics Team The Institute of Cancer Research London UK., Amin J; Clinical Biochemistry Section Royal Marsden NHS Foundation Trust London UK., Mikropoulos C; Oncogenetics Team The Institute of Cancer Research London UK.; Academic Urology Unit Royal Marsden NHS Foundation Trust London UK., Taylor N; Oncogenetics Team The Institute of Cancer Research London UK.; Academic Urology Unit Royal Marsden NHS Foundation Trust London UK., Myhill K; Oncogenetics Team The Institute of Cancer Research London UK.; Academic Urology Unit Royal Marsden NHS Foundation Trust London UK., Thomas S; Oncogenetics Team The Institute of Cancer Research London UK., Saunders E; Oncogenetics Team The Institute of Cancer Research London UK., Dadaev T; Oncogenetics Team The Institute of Cancer Research London UK., Leongamornlert D; Oncogenetics Team The Institute of Cancer Research London UK., Dyrsø Jensen T; Department of Clinical Genetics Vejle Hospital Vejle Denmark., Evans DG; Genetic Medicine, Manchester Academic Health Sciences Centre Central Manchester University Hospitals NHS Foundation Trust Manchester UK., Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology Pomeranian Medical University in Szczecin Szczecin Poland., Liljegren A; Karolinska University Hospital and Karolinska Institutet Stockholm Sweden., Teo SH; Cancer Research Initiatives Foundation Subang Jaya Medical Centre Selangor Darul Ehsan Malaysia., Side L; Wessex Clinical Genetics Service Princess Anne Hospital Southampton UK., Kote-Jarai Z; Oncogenetics Team The Institute of Cancer Research London UK., Eeles RA; Oncogenetics Team The Institute of Cancer Research London UK.; Academic Urology Unit Royal Marsden NHS Foundation Trust London UK.
Publikováno v:
BJUI compass [BJUI Compass] 2023 Jan 09; Vol. 4 (3), pp. 361-373. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2023).
Autor:
Bancroft EK; Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Page EC; Oncogenetics Team, Institute of Cancer Research, London, UK., Brook MN; Oncogenetics Team, Institute of Cancer Research, London, UK., Thomas S; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Taylor N; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Pope J; Oncogenetics Team, Institute of Cancer Research, London, UK., McHugh J; Oncogenetics Team, Institute of Cancer Research, London, UK., Jones AB; Oncogenetics Team, Institute of Cancer Research, London, UK., Karlsson Q; Oncogenetics Team, Institute of Cancer Research, London, UK., Merson S; Oncogenetics Team, Institute of Cancer Research, London, UK., Ong KR; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK., Hoffman J; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK., Huber C; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK., Maehle L; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Grindedal EM; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Stormorken A; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Evans DG; Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester University NHS Foundation Trust, Manchester, UK., Rothwell J; Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester University NHS Foundation Trust, Manchester, UK., Lalloo F; Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester University NHS Foundation Trust, Manchester, UK., Brady AF; North West Thames Regional Genetics Service, London North West University Healthcare NHS Trust, Harrow, UK., Bartlett M; North West Thames Regional Genetics Service, London North West University Healthcare NHS Trust, Harrow, UK., Snape K; St George's Hospital, Tooting, London, UK., Hanson H; St George's Hospital, Tooting, London, UK., James P; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia., McKinley J; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Mascarenhas L; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Syngal S; Division of Population Sciences, Dana Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA., Ukaegbu C; Division of Population Sciences, Dana Farber Cancer Institute, Boston, MA, USA., Side L; University Hospital Southampton, Southampton, UK; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Thomas T; University Hospital Southampton, Southampton, UK; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Barwell J; Department of Genetics, University of Leicester, Leicester, UK; University Hospitals Leicester, Leicester, UK., Teixeira MR; Genetics Department and Research Center, Portuguese Oncology Institute (IPO Porto), Porto, Portugal; Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal., Izatt L; Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK., Suri M; Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK., Macrae FA; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia; Parkville Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, VIC, Australia; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Parkville, VIC, Australia., Poplawski N; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, SA, Australia; Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Chen-Shtoyerman R; The Genetic Institute, Kaplan Medical Center, Rehovot, Israel; Biology Department, Ariel University, Ariel, Israel., Ahmed M; North East Thames Regional Genetics Service, Institute of Child Health, London, UK., Musgrave H; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Nicolai N; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Greenhalgh L; Clinical Genetics Service, Liverpool Women's Hospital, Liverpool, UK., Brewer C; Peninsular Genetics, Derriford Hospital, Plymouth, UK; Royal Devon and Exeter Hospital, Exeter, UK., Pachter N; Genetic Services of Western Australia, King Edward Memorial Hospital, Subiaco, WA, Australia; Department of Paediatrics, University of Western Australia, Perth, WA, Australia., Spigelman AD; Hunter Family Cancer Service, Waratah, NSW, Australia; University of New South Wales, St Vincent's Clinical School, NSW, Australia; Cancer Genetics Clinic, The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia., Azzabi A; Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Helfand BT; John and Carol Walter Center for Urological Health, Division of Urology, NorthShore University HealthSystem, Evanston, IL, USA., Halliday D; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK., Buys S; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Ramon Y Cajal T; Hospital de Sant Pau, Barcelona, Spain., Donaldson A; St Michael's Hospital, Bristol, UK., Cooney KA; Duke Cancer Institute and Duke University School of Medicine, Durham, NC, USA., Harris M; Monash Health, Clayton, VIC, Australia; Monash University, Clayton, VIC, Australia., McGrath J; Royal Devon and Exeter Hospital, Exeter, UK; University of Exeter Medical School, St Luke's Campus, Exeter, UK., Davidson R; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK., Taylor A; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK., Cooke P; New Cross Hospital, Wolverhampton, UK., Myhill K; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Hogben M; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Aaronson NK; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Ardern-Jones A; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Bangma CH; Department of Urology, Erasmus Cancer Institute, Erasmus University Medical Centre, Rotterdam, Netherlands., Castro E; Spanish National Cancer Research Center, Madrid, Spain., Dearnaley D; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, Surrey, UK., Dias A; Instituto Nacional de Cancer Jose de Alencar Gomes da Silva INCA, Rio de Janeiro, Brazil., Dudderidge T; University Hospital Southampton, Southampton, UK., Eccles DM; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK; Faculty of Medicine, University of Southampton, Southampton, UK., Green K; Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester University NHS Foundation Trust, Manchester, UK., Eyfjord J; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland., Falconer A; Imperial College Healthcare NHS Trust, London, UK., Foster CS; HCA Pathology Laboratories, London, UK., Gronberg H; University Hospital of Umeå, Umeå, Sweden., Hamdy FC; Churchill Hospital, Headington, Oxford, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Johannsson O; Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland., Khoo V; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; St George's Hospital, Tooting, London, UK; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, Surrey, UK., Lilja H; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Laboratory Medicine, Department of Surgery, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Lindeman GJ; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia; Parkville Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, VIC, Australia; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland., Axcrona K; Department of Urology, Akershus University Hospital, Lørenskog, Norway., Mikropoulos C; Royal Surrey County Hospital, Guildford, UK., Mitra AV; University College London Hospitals NHS Foundation Trust, London, UK., Moynihan C; Oncogenetics Team, Institute of Cancer Research, London, UK., Ni Raghallaigh H; Oncogenetics Team, Institute of Cancer Research, London, UK., Rennert G; CHS National Cancer Control Center, Carmel Medical Center, Haifa, Israel., Collier R; Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK., Offman J; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, Guy's Cancer Centre, Guy's Hospital, London, UK., Kote-Jarai Z; Oncogenetics Team, Institute of Cancer Research, London, UK., Eeles RA; Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: ros.eeles@icr.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Nov; Vol. 22 (11), pp. 1618-1631. Date of Electronic Publication: 2021 Oct 19.
Autor:
Bancroft EK; Urology Genetics, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT, UK.; Oncogenetics Team, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK., Raghallaigh HN; Urology Genetics, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT, UK.; Oncogenetics Team, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK., Page EC; Urology Genetics, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT, UK.; Oncogenetics Team, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK., Eeles RA; Urology Genetics, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT, UK.; Oncogenetics Team, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK.
Publikováno v:
Current genetic medicine reports [Curr Genet Med Rep] 2021; Vol. 9 (4), pp. 47-58. Date of Electronic Publication: 2021 Oct 08.